MS417

For research use only. Not for therapeutic Use.

  • CAT Number: I008209
  • CAS Number: 916489-36-6
  • Molecular Formula: C20H19ClN4O2S
  • Molecular Weight: 414.91
  • Purity: ≥95%
Inquiry Now

MS417(Cat No.:I008209)is a selective inhibitor of the protein kinase IKKβ (IκB kinase β), a key regulator of the NF-κB signaling pathway, which is involved in inflammation and cancer progression. By targeting IKKβ, MS417 disrupts NF-κB activation, leading to reduced inflammatory responses and potential anti-tumor effects. This compound has shown efficacy in preclinical studies, particularly in cancers characterized by elevated NF-κB activity. MS417’s ability to modulate inflammatory pathways positions it as a promising candidate for therapeutic development, especially in treating inflammatory diseases and cancers driven by aberrant NF-κB signaling.


Catalog Number I008209
CAS Number 916489-36-6
Synonyms

MS417; MS-417; MS 417; GTPL7512; GTPL-7512; GTPL 7512.;methyl (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate

Molecular Formula C20H19ClN4O2S
Purity ≥95%
Solubility Soluble in DMSO, not in water
Storage 0 - 4 °C for short term, or -20 °C for long term
IUPAC Name methyl 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate
InChI InChI=1S/C20H19ClN4O2S/c1-10-11(2)28-20-17(10)18(13-5-7-14(21)8-6-13)22-15(9-16(26)27-4)19-24-23-12(3)25(19)20/h5-8,15H,9H2,1-4H3/t15-/m0/s1
InChIKey GGRCIHACOIMRKY-HNNXBMFYSA-N
SMILES CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C
Reference

</br> 1:Hu Y, Zhou J, Ye F, Xiong H, Peng L, Zheng Z, Xu F, Cui M, Wei C, Wang X, Wang Z, Zhu H, Lee P, Zhou M, Jiang B, Zhang DY. BRD4 inhibitor inhibits colorectal cancer growth and metastasis. Int J Mol Sci. 2015 Jan 16;16(1):1928-48. doi: 10.3390/ijms16011928. PubMed PMID: 25603177; PubMed Central PMCID: PMC4307342.</br> 2: Liu R, Zhong Y, Li X, Chen H, Jim B, Zhou MM, Chuang PY, He JC. Role of transcription factor acetylation in diabetic kidney disease. Diabetes. 2014 Jul;63(7):2440-53. doi: 10.2337/db13-1810. Epub 2014 Mar 7. PubMed PMID: 24608443; PubMed Central PMCID: PMC4066331.

Request a Quote